Neurogenic modifications induced by substance P in an organ culture of human skin

Skin Pharmacology and Applied Skin Physiology

Volumn 12, Issue 4, 1999, Pages 211-220

  Branchet Gumila, M C ^a,b   Boisnic, S ^a,b,d   Le Charpentier, Y ^a   Nonotte, I ^c   Montastier, C ^c   Breton, L ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Grp Rech Dermatol et Cosmetologie   (France)

^c L ORÉAL RECHERCHE   (France)

^d Serv Ctrl d'Anat Cytologie P   (France)

Author keywords

Neurogenic inflammation; Organ culture of human skin; Substance P

Indexed keywords

INTERLEUKIN 1ALPHA; IRRITANT AGENT; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; EPIDERMIS; EXTRAVASATION; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTE; MAST CELL; NEUROGENIC INFLAMMATION; PRIORITY JOURNAL; SKIN CULTURE; SKIN INFLAMMATION; VASODILATATION;

EID: 0032776055     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066245     Document Type: Article

References (31)

1. Lynch DR, Snyder SH: Neuropeptides: Multiple molecular forms, metabolic pathways and receptors. Annu Rev Biochem 1986;55:773-799.
2. Nikkels-Tassoudji N, Nikkels AF, Pierard GE: Cutaneous neuropeptides. Nouv Dermatol 1994;13:767-772.
3. Eedy DJ: Neuropeptides in skin. Br J Dermatol 1993;128:597-605.
4. Lotti T, Hautmann G, Panconesi E: Neuropeptides in skin. J Am Dermatol 1995;33:482-496.
5. Lembeck F, Gamse R; Substance P in peripheral sensory processes; in Porter R, O'Connor M (eds): Substance in the Nervous System. Ciba Foundation Symposium 91. London, Pitman, 1982, pp 284-298.
6. Jorizzo JL, Coutts AA, Eady RAJ, Greaves MW: Vascular responses of human skin to injection of substance P and mechanism of action. Eur J Pharmacol 1983;87:67-76.
7. Cappugi P, Tsampau D, Lotti T: Substance P provokes cutaneous erythema and edema through a histamine-independent pathway. Int J Dermatol 1992;31:206-209.
8. Fantini F, Magnoni C, Pincelli C, Giannetti A: Neurogenic inflammation and the skin: Neural modulation of cutaneous inflammatory reactions. Eur J Dermatol 1995;5: 349-357.
9. Pincelli C, Fantini F, Giannetti A: Neuropeptides and skin inflammation. Dermatology 1993;187:153-158.
10. Ebertz JM, Hirshman CA, Kettelkamp NS, Uno H, Hanifin JM: Substance P-induced histamine release in human cutaneous mast cells. J Invest Dermatol 1987;88:682-685.
11. Matis WL, Lavker RM, Murphy GF: Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium. J Invest Dermatol 1990;94:492-495.
12. Tomoe S, Iwamoto I, Tomoika H: Comparison of substance P induced and compound 48/80-induced neutrophil infiltrations in mouse skin. Int Arch Allergy Appl Immunol 1992;97:237-242.
13. Ruff MR, Wahl SM, Pert CB: Substance P receptor-mediated chemotaxis of human monocytes. Peptides 1985;6:101-111.
14. Piotrowski W, Devoy MAB, Jordan CC: The substance P receptor on rat mast cells and in human skin. Agents Actions 1984;14:420-424.
15. Watson SP: Are the proposed substance P receptor subtypes, substance P receptor? Life Sci 1984;35: 797-808.
16. Von Restoroff B, Kemeny L, Mihel G: Specific binding of substance P in normal human keratinocytes (abstract). J Invest Dermatol 1992;98: 510.
17. Boisnic S, Branchet-Gumila MC, Benslama L, Le Charpentier Y, Arnaud-Battandier J: Efficacy of a hydroxy acid-containing cream on long-term organ culture of human nonstimulated skin. Eur J Dermatol 1997;7:271-273.
18. Chapman SJ, Walsh A, Beckett E, Vickers CFH: A fully differentiating epidermal model with extended viability: Development and partial characterization. J Invest Dermatol 1989;93:762-768.
19. Kondo S, Hozumi Y, Aso K: Long-term organ culture of rabbit skin: Effect of EGF on epidermal structure in vitro. J Invest Dermatol 1990;95:397-402.
20. McKensie RC, Sauder DN: The role of keratinocyte cytokines in inflammation and immunity. J Invest Dermatol 1993;95:105S-107S.
21. Lewis T: Observations upon reactions of vessels in human skin to cold. Heart 1930;15:177.
22. Hägermark O, Hökfelt T, Pernow B: Flare and itch induced by substance P in human skin. J Invest Dermatol 1978;71:233-235.
23. Brain SD: Sensory neuropeptides in the skin; in Geppetti P, Holzer P (eds): Neurogenic Inflammation. Boca Raton, CRC Press, 1996, pp 229-244.
24. Smith CH, Baker JN, Morris RW, MacDonald DM, Lee TH: Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol 1993;151: 3274-3282.
25. Numao T, Agrawal DK: Neuropeptides modulate human eosinophil chemotaxis. J Immunol 1992;149: 3309-3315.
26. Dannenberg AM, Moore KG: Toxic and allergic skin reactions evaluated in organ-cultured full-thickness human and animal skin explants; in Rougier A, Goldberg AM, Maibach HI (eds): In vitro Skin Toxicology Irritation, Phototoxicity, Sensitization. New York, Liebert Inc, 1994, pp 351-366.
27. Staniek V, Misery L: Substance P et peau humaine. Pathol Biol (Paris) 1996;44:860-866.
28. Lotz M, Vaughan JH, Carson DA: Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241:1218-1221.
29. Ansel JC, Brown JR, Payan DG, Brown MA: Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 1993;150:4478-4485.
30. Viac J, Gueniche A, Doutremepuich JD, Reichert U, Claudy A, Schmitt D: Substance P and keratinocyte activation markers: An in vitro approach. Arch Dermatol Res 1996; 288:85-90.
31. Van de Sandt JJM, Bos TA, Rutten JJL: Epidermal cell proliferation and terminal differentiation in skin organ culture after topical exposure to sodium dodecyl sulphate. In Vitro Cell Dev Biol 1995;31:761-766.